Latest filing published 30 Apr 2026 for HCA Healthcare, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Michael W. Michelson, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in HCA Healthcare, Inc. and Zimmer Biomet Holdings, Inc. Between 25 April 2022 and 28 April 2026, the trades on record add up to 6 filings.
Purchases make up the whole of the open-market record (1 purchase, €139k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 5 share grants.
On 30 April 2026 came the latest disclosure, a share grant in HCA Healthcare, Inc. The most recent open-market purchase was published on 29 August 2023, 1,146 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations